Eppendorf expands manufacturing in the U.S.
Since 1998, Eppendorf has manufactured bioreagents in Boulder, Colorado. The new plant on the East coast will allow for additional growth in the Life Sciences segment and reflects the importance and requirements of the U.S. market. The choice of Connecticut was supported by the existence of the so-called "plastic corridor" which provides excellent conditions for industrial manufacturing of high quality consumables.
"Enfield makes a perfect fit for Eppendorf, because our requirements were met to a high degree", Klaus Fink, CEO of Eppendorf AG, explains. "Strategically, our targets include vicinity to our markets, logistical advantages as well as reduced corporate exposure to currency exchange rates."
Other news from the department manufacturing
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.